ShopSpell

Racing to a Cure: A Cancer Victim Refuses Chemotherapy and Finds Tomorrow's Cures in Today's Scientific Laboratories [Paperback]

$31.99       (Free Shipping)
15 available
  • Category: Books (Medical)
  • Author:  Ruzic, Neil
  • Author:  Ruzic, Neil
  • ISBN-10:  0252073576
  • ISBN-10:  0252073576
  • ISBN-13:  9780252073571
  • ISBN-13:  9780252073571
  • Publisher:  University of Illinois Press
  • Publisher:  University of Illinois Press
  • Pages:  456
  • Pages:  456
  • Binding:  Paperback
  • Binding:  Paperback
  • Pub Date:  01-May-2006
  • Pub Date:  01-May-2006
  • SKU:  0252073576-11-SPLV
  • SKU:  0252073576-11-SPLV
  • Item ID: 105335111
  • Seller: ShopSpell
  • Ships in: 2 business days
  • Transit time: Up to 5 business days
  • Delivery by: Sep 26 to Sep 28
  • Notes: Brand New Book. Order Now.
Racing to a Cureis not a cancer memoir. It is a cancer cure memoir. In 1998 Neil Ruzic was diagnosed with mantle-cell lymphoma, the deadliest cancer of the lymph system, whose spread is reaching epidemic levels in the U.S. and Europe. Instead of following recommended courses of chemotherapy and radiation, he took control of his treatment by investigating cures being developed in the nation's cancer-research laboratories.

Although chemotherapy harms the immune system and is increasingly demonstrated to be an ineffective long-term cure for the vast majority of cancers, it remains the standard treatment for most cancer patients. Ruzic, a former scientific magazine publisher and originator of a science center, refused to accept this status quo, and instead plunged into the world of cutting-edge treatments, exploring the frontiers of cancer science with revolutionary results.

Ruzic went on the offensive: visiting scores of laboratories, gathering information, talking to researchers, and effectively becoming his own patient-care advocate. This book presents his findings. A scathing critique of the chemotherapy culture as well as unscientific "alternative" therapies, the book endorses state-of-the-art molecularly based technologies, making it an illuminating and necessary read for anyone interested in cancer research, especially patients and their families and physicians.

Neil Ruzic was expected to die within two years of his initial diagnosis. Five years later he has been declared cancer-free and considers himself cured.

In September 1998 publisher and scientific journalist Ruzic was diagnosed with mantle-cell lymphoma. . . . He faced a prognosticated further life-span of 18 months, and that would be made insufferable by side effects from the prescribed chemotherapy. . . . His scientific mind was certain that there were other, perhaps more effective and certainly less deadly treatment options, if one could find them. He made finding l“´
Add Review